Proteinuria e trapianto di rene

Abstract

Get full access to this article

View all access options for this article.

References

Haraldsson

, Nystrom

, Deen

W.M.

Properties of the Glomerular Barrier and Mechanisms of Proteinuria. Physiol Rev 2008; 88: 451–87.

Cirillo

Evaluation of glomerular filtration rate and of albuminuria/proteinuria. J Nephrol 2010; 23: 125–32.

Knoll

G.A.

Proteinuria in Kidney Transplant Recipients: Prevalence, Prognosis, and Evidence-Based Management. Am J Kidney Dis 2009; 54: 1131–44.

Sancho

, Gavela

, Avila

. Risk factors and pro-gnosis for proteinuria in renal transplant recipients. Transplant Proc 2007; 39: 2145–7.

Halimi

J.M.

, Laouad

, Buchler

. Early low grade proteinuria: Causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant 2005; 5: 2281–8.

Amer

, Fidler

M.E.

, Myslak

. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 2007; 7: 2748–56.

Halimi

, Laouad

, Buchler

. Early proteinuria is a strong indicator of donor renal lesions, ischemia-reperfusion injury and immunological aggression. Transplant Proc 2006; 38: 2319–20.

First

M.R.

, Vaidya

P.N.

, Maryniak

R.K.

. Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation 1984; 38: 607–12.

Yakupoglu

, Baranowska-Daca

, Rosen

. Post-transplant nephrotic syndrome: A comprehensive clinicopathologic study. Kidney Int 2004; 65: 2360–70.

10.

Fotheringham

, Angel

C.A.

, McKane

Transplant glomerulopathy: morphology, associations and mechanism. Nephron Clin Pract 2009; 113: c1–7.

11.

Sarafidis

P.A.

, Bakris

G.L.

Renin-angiotensin blockade and kidney disease. Lancet. 2008; 372: 511–2.

12.

Bakris

G.L.

Slowing nephropathy progression: focus on proteinuria reduction. Clin J Am Soc Nephrol 2008; 3(Suppl 1): S3–10.

13.

Hiremath

, Fergusson

, Doucette

. Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence. Am J Transplant 2007; 7: 2350–60.

14.

Heinze

, Mitterbauer

, Regele

. Angiotensin Converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889–99.

15.

Opelz

, Zeier

, Lau

. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A Collaborative Transplant Study Report. J Am Soc Nephrol 2006; 17: 3257–62.

16.

Myslak

, Amer

, Morales

. Interpretino post-transplant proteinuria in patients with proteinuria pretransplant. Am J Transplant 2006; 6: 1660–5.

17.

Biancone

, Bussolati

, Mazzucco

. Loss of nephrin expression in glomeruli of kidney-transplanted patients under mTOR inhibitor therapy. Am J Transplant 2010; 10: 2270–8.

18.

Franz

, Regeniter

, Hopfer

. Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial. Am J Kidney Dis 2010; 55: 335–43. Epub 2009 Nov 17.

19.

Schena

F.P.

Review of symposium. Sirolimus in kidney transplantation. Transplantation. 2009; 27; 87(Suppl 8): S30–3.